General Information of This Drug (ID: DMUYNEI)

Drug Name
Amoxicillin   DMUYNEI
Synonyms
AMPC; Actimoxi; Amoclen; Amolin; Amopen; Amopenixin; Amoxi; Amoxibiotic; Amoxicaps; Amoxicilina; Amoxicillanyl; Amoxicilline; Amoxicillinum; Amoxiden; Amoxil; Amoxivet; Amoxycillin; Anemolin; Aspenil; Biomox; Bristamox; Cemoxin; Clamoxyl; Delacillin; DisperMox; Efpenix; Flemoxin; Hiconcil; Histocillin; Hydroxyampicillin; Ibiamox; Imacillin; Lamoxy; Larotid; Moxacin; Moxal; Moxatag; Ospamox; Pamoxicillin; Piramox; Polymox; Robamox; Sumox; Tolodina; Trimox; Unicillin; Utimox; Vetramox; Wymox; AMOXICILLIN CRYSTALLINE; AMOXICILLIN PEDIATRIC; Amoxicillin anhydrous; Amoxicilline [INN]; Amoxycillin Trihydrate; Metafarma capsules; Metifarma capsules; Sawamox PM; BLP 1410; AMK (TN); Actimoxi (TN); Alphamox (TN); Amoksibos (TN); Amoksiklav (TN); Amoxi-Mast; Amoxibiotic (TN); Amoxicilina (TN); Amoxicilina [INN-Spanish]; Amoxicillin (INN); Amoxicillin (TN); Amoxicillin (anhydrous); Amoxicilline [INN-French]; Amoxicillinum [INN-Latin]; Amoxiclav (TN); Amoxidal (TN); Amoxil (TN); Amoxin (TN); Apo-Amoxi; Augmentin (TN); BL-P 1410; BRL-2333; Bactox (TN); Betalaktam (TN); Cilamox (TN); Clamoxyl (TN); Curam (TN); D-Amoxicillin; Dedoxil (TN); Dispermox (TN); Duomox (TN); Enhancin (TN); Geramox (TN); Gimalxina (TN); Hiconcil (TN); Isimoxin (TN); Klavox (TN); Lamoxy (TN); Moxatag (TN); Moxilen (TN); Moxypen (TN); Moxyvit (TN); Nobactam (TN); Novamoxin (TN); Ospamox (TN); P-Hydroxyampicillin; Pamoxicillin (TN); Panamox (TN); Panklav (TN); Polymox (TN); Ro 10-8756; Samthongcillin (TN); Sandoz (TN); Senox (TN); Sinacilin (TN); Tolodina (TN); Trimox (TN); Wymox (TN); Yucla (TN); Zerrsox (TN); Zimox (TN); Apo-Amoxi (TN); Alpha-Amino-p-hydroxybenzylpenicillin; D-2-Amino-2-(4-hydroxyphenyl)acetamidopenicillanic acid; D-(-)-alpha-Amino-p-hydroxybenzylpenicillin; (-)-6-(2-Amino-2-(P-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo-(3.2.0)heptane-2-carboxylic acid; (2S,5R,6R)-6-[[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; (2S,5R,6R)-6-{[(2R)-2-amino-2-(4-hydroxyphenyl)acetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(2-amino-2-(p-hydroxyphenyl)acetamido)-3,3-dimethyl-7-oxo-, D-(8CI); 6-(D-(-)-alpha-Amino-p-hydroxyphenylacetamido)penicillanic acid; 6-(D-(-)-p-Hydroxy-alpha-aminobenzyl)penicillin; 6-(p-Hydroxy-alpha-aminophenylacetamido)penicillanic acid; 6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carbonyl; 6beta-[(2R)-2-amino-2-(4-hydroxyphenyl)acetamido]-2,2-dimethylpenam-3alpha-carboxylic acid
Indication
Disease Entry ICD 11 Status REF
Acute otitis media AB00 Approved [1]
Bacterial infection 1A00-1C4Z Approved [2]
Staphylococcus aureus infection N.A. Approved [1]
Streptococcal pneumonia N.A. Approved [1]
Urinary tract infection GC08 Approved [1]
Pneumonia due to Klebsiella pneumoniae CA40.03 Investigative [1]
Sinusitis CA0A.Z Investigative [1]
⏷ Show the Full List of Indication(s)
Therapeutic Class
Antibiotics
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

List of Combinatorial Drugs (CBD) Containing This Drug

1 Investigative Drug Combination(s) Consisting of This drug
Normalized Drug Combination Synergy Score
Synergy scores were normalized using Min-Max Scaling to facilitate visual comparisons.
DrugCom Name DrugCom ID Component Drug Indication REF
Clavulanate + Amoxicillin DCW5U5J Clavulanate Infectious disease (Cell Line: .) [2]
------------------------------------------------------------------------------------
33 Clinical Trial Drug Combination(s) Consisting of This drug
DrugCom Name DrugCom ID Component Drug Indication REF
Clarithromycin + Amoxicillin DC7PA0V Clarithromycin Drug Interaction [3]
Doxycycline + Amoxicillin DCHVXBY Doxycycline Periodontitis [4]
Esomeprazole + Amoxicillin DCU8C52 Esomeprazole Helicobacter Pylori Infection [5]
Ketoprofen + Amoxicillin DCSB80R Ketoprofen Pharyngotonsillitis [6]
Rabeprazole + Amoxicillin DCCVWWH Rabeprazole Helicobacter Pylori Infection [7]
Vonoprazan + Amoxicillin DCHMOXE Vonoprazan Helicobacter Pylori Infection [8]
Clarithromycin + Amoxicillin DC1GAFQ Clarithromycin Helicobacter Pylori Infection [9]
Clarithromycin + Amoxicillin DCF1IST Clarithromycin Acid Dyspepsia [10]
Ertapenem + Amoxicillin DCSHRQ0 Ertapenem Pulmonary Tuberculosis [11]
Meropenem + Amoxicillin DCVF97B Meropenem Pulmonary Tuberculosis [11]
Rabeprazole + Amoxicillin DC91EA6 Rabeprazole Helicobacter Pylori Infection [12]
Rifampicin + Amoxicillin DC7HP6G Rifampicin Pulmonary Tuberculosis [11]
Clarithromycin + Amoxicillin DC3BGTZ Clarithromycin Helicobacter Pylori Infection [13]
Clarithromycin + Amoxicillin DC8N0YC Clarithromycin H. Pylori Infection [14]
Vonoprazan + Amoxicillin DCMFNTG Vonoprazan Helicobacter Pylori Infection [13]
Amoxicillin + Lansoprazole DC78BD9 Lansoprazole Functional Dyspepsia [15]
Amoxicillin + Tetracycline DC66HUF Tetracycline Antimicrobial Susceptibility Testing [16]
Chlorhexidine + Amoxicillin DCDAYAJ Chlorhexidine Medication Related Osteonecrosis of the Jaw [17]
Clarithromycin + Amoxicillin DCQQMYT Clarithromycin Helicobacter Pylori Infection [18]
Clarithromycin + Amoxicillin DCEOFR6 Clarithromycin Peptic Ulcer [19]
Clarithromycin + Amoxicillin DCWZIOF Clarithromycin Antimicrobial Susceptibility Testing [16]
Esomeprazole + Amoxicillin DCZGJ2O Esomeprazole Helicobacter Pylori Infection [20]
Furazolidone + Amoxicillin DC52YI1 Furazolidone Functional Dyspepsia [15]
Furazolidone + Amoxicillin DCH2OEO Furazolidone Antimicrobial Susceptibility Testing [16]
Levofloxacin + Amoxicillin DC6FL5U Levofloxacin Functional Dyspepsia [21]
Levofloxacin + Amoxicillin DC5JOLC Levofloxacin Antimicrobial Susceptibility Testing [16]
Metronidazole + Amoxicillin DC3KA67 Metronidazole Peptic Ulcer [19]
Metronidazole + Amoxicillin DCDN60Y Metronidazole Periodontal Diseases [22]
Metronidazole + Amoxicillin DCE3SHQ Metronidazole Generalized Aggressive Periodontitis [23]
Omeprazole + Amoxicillin DC1DU43 Omeprazole Helicobacter Pylori Infection [24]
Rabeprazole + Amoxicillin DC2DHYZ Rabeprazole Helicobacter Pylori Infection [25]
Tindamax + Amoxicillin DC88B5V Tindamax Antimicrobial Susceptibility Testing [16]
Vonoprazan + Amoxicillin DCI69N4 Vonoprazan Helicobacter Pylori Infection [26]
------------------------------------------------------------------------------------
⏷ Show the Full List of 33 DrugCom(s)

References

1 Amoxicillin FDA Label
2 Emerging therapies for the treatment and prevention of otitis media. Expert Opin Emerg Drugs. 2006 May;11(2):251-64.
3 ClinicalTrials.gov (NCT03011996) To Investigate PK and PD of CJ-12420, Clarithromycin, Amoxicillin After Multiple Dose Administration
4 ClinicalTrials.gov (NCT00066066) Effect of Three Periodontal Therapies in Current Smokers and Non-Smokers
5 ClinicalTrials.gov (NCT03383003) Comparison of Two Novel First-line Anti-Helicobacter Pylori Therapy
6 ClinicalTrials.gov (NCT00799838) Evaluation of Inflammatory Symptoms Reduction With Amoxicillin + Ketoprofen in Acute Pharyngeal Tonsillitis in Pediatric Patients
7 ClinicalTrials.gov (NCT05152004) Efficacies of Hybrid and High-dose Dual Therapies for the First-line Anti-H Pylori Treatment
8 ClinicalTrials.gov (NCT05189444) The Evaluation of Triple Therapy With Vonoprazan, Amoxicillin and Bismuth for Eradication of Helicobacter Pylori
9 ClinicalTrials.gov (NCT05861687) Recurrence Rate Comparison Between Esomeprazole and Lansoprazole in Eradicating Helicobacter Pylori Infection Among Children
10 ClinicalTrials.gov (NCT03428568) Safety Trial of Herbal Melanin in Gastritis Patients
11 ClinicalTrials.gov (NCT05896930) Study to Evaluate EBA, Safety and Tolerability of Carbapenems in Adults With Pulmonary Tuberculosis
12 ClinicalTrials.gov (NCT06076694) Efficacy and Safety After Multiple Doses of TNP-2198 Capsules, Rabeprazole Sodium Enteric-coated Tablets and Amoxicillin Capsules in Helicobacter Pylori Infected-positive Participants
13 ClinicalTrials.gov (NCT04167670) Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Helicobacter Pylori Infection
14 ClinicalTrials.gov (NCT01505127) Efficacy of TAK-438, Amoxicillin and Clarithromycin in the First Line Eradication of H. Pylori
15 ClinicalTrials.gov (NCT01668927) Empirical Rescue Therapies of Helicobacter Pylori Infection
16 ClinicalTrials.gov (NCT03139253) Antimicrobial Susceptibility Testing Guided Triple Therapy in Salvage Helicobacter Pylori Treatment
17 ClinicalTrials.gov (NCT04512638) Best Treatment Choice for Osteonecrosis of the Jaw
18 ClinicalTrials.gov (NCT03124420) Intraluminal Therapy for Helicobacter Pylori Infection
19 ClinicalTrials.gov (NCT02648659) The Pilot Study on Tailored Eradication Therapy According to Clarithromycin Resistance in H.Pylori Patients
20 ClinicalTrials.gov (NCT04024527) High Dose of Dual Therapy Plus Metronidazole for Helicobacter Pylori RescueTreatment
21 ClinicalTrials.gov (NCT01667718) Bismuth Improves the Efficacy of Levofloxacin-containing Triple Therapy for Helicobacter Pylori Treatment
22 ClinicalTrials.gov (NCT02185209) Surgical Treatment of Peri-implantitis With and Without Systemically Adjunctive Antibiotics
23 ClinicalTrials.gov (NCT02223702) Alternative Antibiotic Regime in the Treatment of GAgP
24 ClinicalTrials.gov (NCT05342532) High Dose Dual Therapy vs Clarithromycin Triple Therapy for Treatment Naive H Pylori Infection in an Urban Population
25 ClinicalTrials.gov (NCT05061732) Helicobacter Pylori Eradication and Follow-up
26 ClinicalTrials.gov (NCT05419674) Efficacy and Safety of Dual Therapy as First-line Treatment for Hp Infection